Natural product antibiotics and analogs thereof

US9359275B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9359275-B2
Application numberUS-201313776144-A
CountryUS
Kind codeB2
Filing dateFeb 25, 2013
Priority dateFeb 23, 2012
Publication dateJun 7, 2016
Grant dateJun 7, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are pure and isolated natural products and analogs thereof of Formula (I), (II), (III), and (IV), pharmaceutical compositions thereof, and methods of use, for example, for treating a bacterial infection. Further provided are methods useful in identifying an inhibitor of bacterial sugar fermentation in a bacterial strain, such as a compound (inhibitor) of Formula (I), (II), (III), or (IV): or a pharmaceutically acceptable salt thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating a bacterial infection in a subject comprising administering an effective amount of a compound of Formula (I-b): or pharmaceutically acceptable salt thereof, to the subject; wherein: each occurrence of R A , R B , and R C is hydrogen; R 3 is unsubstituted C 2 -C 10 alkyl, wherein the bacterial infection is an Escherichia coli, Pseudomonas aeruginosa, Vibrio cholerae , methicillin-resistant Staphylococcus aureus , or Mycobacterium tuberculosis infection. 2. The method of claim 1 wherein R 3 is unsubstituted C 2 -C 6 alkyl. 3. The method of claim 1 wherein the compound is of Formula (I-c): or a pharmaceutically acceptable salt thereof. 4. The method of claim 1 wherein the compound is: or a pharmaceutically acceptable salt thereof. 5. The method of claim 1 , wherein the bacterial infection is a methicillin-resistant Staphylococcus aureus infection. 6. The method of claim 1 , wherein the bacterial infection is a Mycobacterium tuberculosis infection. 7. The method of claim 1 , wherein the bacterial infection is a methicillin-resistant Staphylococcus aureus infection or a Mycobacterium tuberculosis infection.

Assignees

Inventors

Classifications

  • Oxygen atoms · CPC title

  • A61K31/122Primary

    having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin · CPC title

  • Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol · CPC title

  • A61K31/351Primary

    not condensed with another ring · CPC title

  • containing —CHO or non—quinoid keto groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9359275B2 cover?
Provided herein are pure and isolated natural products and analogs thereof of Formula (I), (II), (III), and (IV), pharmaceutical compositions thereof, and methods of use, for example, for treating a bacterial infection. Further provided are methods useful in identifying an inhibitor of bacterial sugar fermentation in a bacterial strain, such as a compound (inhibitor) of Formula (I), (II), (III)…
Who is the assignee on this patent?
Childrens Medical Center, Harvard College
What technology area does this patent fall under?
Primary CPC classification A61K31/122. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).